Association of ankylosing spondylitis and crohn's disease successfully treated with infliximab

BioDrugs

Volumn 24, Issue SUPPL. 1, 2010, Pages 37-39

  Rebelo, Ana ^a   Leite, Sílvía ^a   Cotter, José ^a  

^a Gastroenterology Department   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; INFLIXIMAB; NAPROXEN; PREDNISOLONE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE ENDOSCOPY; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; HUMANS; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650432427     PISSN: 11738804     EISSN: 1179190X     Source Type: Journal    
DOI: 10.2165/11586220-000000000-00000     Document Type: Article

References (9)

1. Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Practice Res Clin Rheumatol 2006 Jun 01; 20 (3): 451-71
2. Salvarani C, Fries W. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World J Gastroenterol 2009; 15 (20): 2449-55
3. Singh S, Graff LA, Bernstein CN. Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol 2009; 104: 1298-313
4. Generini S, Giacomelli R, Fedi R, et al. Infliximab in spondyloarthropathy associated with Crohn's disease: An open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations. Ann Rheum Dis 2004; 63: 1664-9
5. Maksymowych WP. Update on the treatment of ankylosing spondylitis. Ther Clin Risk Manag 2007; 3: 1125-33
6. Atzeni F, Ardizzone S, Bertani L, et al. Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis. World J Gastroenterol 2009; 15 (20): 2469-71
7. Braun J, Baraliakos X, Listing J, et al. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Arthritis Rheum 2007; 57: 639-47
8. Portela F. Terapêutica farmacoló gica da doença de Crohn. Jornal Português de Gastrenterologia 2009 Março/Abril; 16 (2): 52-5
9. Magro F, Portela F. Doença Inflamató ria Intestinal. Tó picos de relevâ ncia clínica, 1a ed. GEDII (Grupo de Estudo da Doença Inflamató ria Intestinal) - Portugal 2008; 247-282